Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

Heart Failure Society of America (HFSA 2026) 9 - 12 October 2026

Inflammatory biomarkers in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) treated with coramitug: post hoc analysis of a phase 2 randomized trial

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Cardiovascular Disease
Congress poster
Anti-TTR monoclonal antibody
Coramitug
PHASE 2 (RCT)